about
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial.Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory Study.HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis.Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial.Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia.Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients
P50
Q36033253-5FBC1E68-24E4-40E3-902A-DC077B049E35Q36325773-373C0923-F430-4668-9ED3-B1318531799EQ36950578-350C28DB-A169-4A7F-B435-D9A50231AFACQ40898013-B85CD1E6-B467-48E2-8FBB-8B65F4FEABA5Q45985388-6C8274AC-385A-4465-91DD-7D90F1B7A98EQ47966192-FF982DC3-A911-49DE-AE4A-7C8A050EF326Q48087061-910A14ED-4CF2-4BE7-B129-04C647813E1EQ60627939-D814DC92-5C98-49A2-9BF2-5F00BC2B49B6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yosuke Koshikawa
@ast
Yosuke Koshikawa
@en
Yosuke Koshikawa
@es
Yosuke Koshikawa
@nl
type
label
Yosuke Koshikawa
@ast
Yosuke Koshikawa
@en
Yosuke Koshikawa
@es
Yosuke Koshikawa
@nl
prefLabel
Yosuke Koshikawa
@ast
Yosuke Koshikawa
@en
Yosuke Koshikawa
@es
Yosuke Koshikawa
@nl
P106
P31
P496
0000-0002-6736-092X